Innoviva (INVA) Gross Profit (2011 - 2026)
Innoviva (INVA) reported Gross Profit of $75.8 million for Q1 2026, up 3.43% on a YoY basis from $73.3 million in Q1 2025, and little changed quarter-over-quarter from $75.5 million in Q3 2025.
Innoviva (INVA) Gross Profit (2011 - 2026) Analysis & Trends
Innoviva has reported Gross Profit for 9 years, with the latest figure at $75.8 million in Q1 2026.
- For the quarter ending Q1 2026, Gross Profit rose 3.43% year-over-year to $75.8 million; the trailing twelve-month figure through Mar 2026 stood at $307.8 million (up 5.64% YoY), and the FY2025 full-year result was $307.7 million, up 3.87% from the prior year.
- Gross Profit for Q1 2026 stood at $75.8 million, roughly flat from $75.5 million in the prior quarter.
- The five-year high for Gross Profit was $85.0 million in Q2 2024, with the low at -$8.0 million in Q2 2023.
- Historically, Gross Profit has averaged $45.3 million across 5 years, with a median of $67.3 million in 2023.
- Annual changes were most pronounced in 2023 — Gross Profit sank 524.8% — and 2024, when it soared 7573.63%.
- Innoviva's Gross Profit stood at $1.3 million in 2022, then surged by 5073.77% to $67.3 million in 2023, then increased by 8.55% to $73.0 million in 2024, then increased by 3.47% to $75.5 million in 2025, then climbed by 0.39% to $75.8 million in 2026.
- The last three Gross Profit figures came in at $75.8 million (Q1 2026), $75.5 million (Q3 2025), and $83.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Innoviva | 1.65 Bn | 1.05 Bn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.83 Mn |
| Mar 31, 2026 | 75.83 Mn |
| Sep 30, 2025 | 75.54 Mn |
| Sep 30, 2025 | 75.54 Mn |
| Jun 30, 2025 | 83.15 Mn |
| Jun 30, 2025 | 83.15 Mn |
| Mar 31, 2025 | 73.32 Mn |
| Mar 31, 2025 | 73.32 Mn |
| Sep 30, 2024 | 73.01 Mn |
| Sep 30, 2024 | 73.01 Mn |
| Jun 30, 2024 | 84.99 Mn |
| Jun 30, 2024 | 84.99 Mn |
| Mar 31, 2024 | 60.09 Mn |
| Mar 31, 2024 | 60.09 Mn |
| Sep 30, 2023 | 67.26 Mn |
| Sep 30, 2023 | 67.26 Mn |
| Jun 30, 2023 | -8.00 Mn |
| Jun 30, 2023 | -8.00 Mn |
| Mar 31, 2023 | -804,000.00 |
| Mar 31, 2023 | -804,000.00 |